Acid Anhydride Hydrolases

"Acid Anhydride Hydrolases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. (Enzyme Nomenclature, 1992) EC 3.6.

Descriptor ID	D017766
MeSH Number(s)	D08.811.277.040
Concept/Terms	Acid Anhydride Hydrolases Acid Anhydride Hydrolases Anhydride Hydrolases, Acid Hydrolases, Acid Anhydride

Below are MeSH descriptors whose meaning is more general than "Acid Anhydride Hydrolases".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Hydrolases [D08.811.277]
Acid Anhydride Hydrolases [D08.811.277.040]

Below are MeSH descriptors whose meaning is related to "Acid Anhydride Hydrolases".

Below are MeSH descriptors whose meaning is more specific than "Acid Anhydride Hydrolases".

Acid Anhydride Hydrolases
AAA Proteins
Adenosine Triphosphatases
Apyrase
GTP Phosphohydrolases
Nucleoside-Triphosphatase
Pyrophosphatases
SAM Domain and HD Domain-Containing Protein 1
Thiamin-Triphosphatase

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Acid Anhydride Hydrolases" by people in this website by year, and whether "Acid Anhydride Hydrolases" was a major or minor topic of these publications.

Bar chart showing 42 publications over 17 distinct years, with a maximum of 7 publications in 1998

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	3	0	3
1998	7	0	7
1999	3	0	3
2000	4	0	4
2001	2	0	2
2002	1	0	1
2003	1	0	1
2004	4	2	6
2005	4	1	5
2007	1	1	2
2009	1	1	2
2010	1	0	1
2012	0	1	1
2014	0	1	1
2016	0	1	1
2024	0	1	1

Below are the most recent publications written about "Acid Anhydride Hydrolases" by people in Profiles.

Calderon-Aparicio A, He J, Simone NL. S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer. Int J Mol Sci. 2024 Sep 28; 25(19).

View in: PubMed
Sun J, Shen R, Schrock MS, Liu J, Pan X, Quimby D, Zanesi N, Druck T, Fong LY, Huebner K. Reduction in squamous cell carcinomas in mouse skin by dietary zinc supplementation. Cancer Med. 2016 08; 5(8):2032-42.

View in: PubMed
Carrillo AM, Bouska A, Arrate MP, Eischen CM. Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene. 2015 Feb 12; 34(7):846-56.

View in: PubMed
Beishline K, Kelly CM, Olofsson BA, Koduri S, Emrich J, Greenberg RA, Azizkhan-Clifford J. Sp1 facilitates DNA double-strand break repair through a nontranscriptional mechanism. Mol Cell Biol. 2012 Sep; 32(18):3790-9.

View in: PubMed
Sun J, Liu J, Pan X, Quimby D, Zanesi N, Druck T, Pfeifer GP, Croce CM, Fong LY, Huebner K. Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Carcinogenesis. 2011 Mar; 32(3):351-8.

View in: PubMed
Sun J, Okumura H, Yearsley M, Frankel W, Fong LY, Druck T, Huebner K. Nit1 and Fhit tumor suppressor activities are additive. J Cell Biochem. 2009 Aug 15; 107(6):1097-106.

View in: PubMed
D'Arca D, LeNoir J, Wildemore B, Gottardo F, Bragantini E, Shupp-Byrne D, Zanesi N, Fassan M, Croce CM, Gomella LG, Baffa R. Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. Urol Oncol. 2010 Mar-Apr; 28(2):189-94.

View in: PubMed
Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, McCorkell KA, Lakshman TV, Collins JE, Wachsberger P, Friedberg JS, Huebner K. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer. 2007 Jan 01; 120(1):24-31.

View in: PubMed
McCorkell KA, Mancini R, Siprashvili Z, Barnoski BL, Iliopoulos D, Siracusa LD, Zanesi N, Croce CM, Fong LY, Druck T, Huebner K. Influence of a nonfragile FHIT transgene on murine tumor susceptibility. Cytogenet Genome Res. 2007; 118(2-4):196-203.

View in: PubMed
Guler G, Uner A, Guler N, Han SY, Iliopoulos D, McCue P, Huebner K. Concordant loss of fragile gene expression early in breast cancer development. Pathol Int. 2005 Aug; 55(8):471-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement